The CBG (cannabigerol) and CBG-A (cannabigerolic acid) are gaining attention in the medical world for their promising therapeutic properties. Known as the 'mother cannabinoids', they are the precursors to other cannabis compounds, such as CBD and THC, and bring benefits without the psychoactive effects that many people associate with the plant.

During cannabis growth, CBG-A naturally transforms into other cannabinoids, but researchers and cultivators have been seeking CBG-rich varieties to facilitate study and clinical use. 

Initial research indicates that CBG may help reduce anxiety and stress, have anti-inflammatory effects, and even act as a neuroprotectant, supporting treatments for degenerative diseases. 

Also read - Why do we need to talk more about CBG?

On the other hand, CBG-A, still relatively unexplored, shows potential in heart protection, reducing oxidative stress, and even preventing certain types of cancer.

One of CBG's differentials is how it interacts with the body. The cannabinoid acts on receptors linked to serotonin and the nervous system, explaining its anxiolytic and neuroprotective effects, helping to modulate the body's natural responses to stress.

Get the free download of the Sechat Cannabis Guide and discover everything about the world of cannabinoids.